KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $182.0 million.

  • Medtronic's Share-based Compensation rose 1446.54% to $182.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $455.0 million, marking a year-over-year increase of 937.5%. This contributed to the annual value of $429.0 million for FY2025, which is 916.03% up from last year.
  • Medtronic's Share-based Compensation amounted to $182.0 million in Q4 2025, which was up 1446.54% from $86.0 million recorded in Q3 2025.
  • Medtronic's Share-based Compensation's 5-year high stood at $182.0 million during Q4 2025, with a 5-year trough of $62.0 million in Q3 2022.
  • In the last 5 years, Medtronic's Share-based Compensation had a median value of $83.5 million in 2024 and averaged $96.9 million.
  • Over the last 5 years, Medtronic's Share-based Compensation had its largest YoY gain of 2000.0% in 2022, and its largest YoY loss of 1014.49% in 2022.
  • Quarter analysis of 5 years shows Medtronic's Share-based Compensation stood at $140.0 million in 2021, then dropped by 2.14% to $137.0 million in 2022, then increased by 6.57% to $146.0 million in 2023, then grew by 8.9% to $159.0 million in 2024, then rose by 14.47% to $182.0 million in 2025.
  • Its last three reported values are $182.0 million in Q4 2025, $86.0 million for Q3 2025, and $89.0 million during Q2 2025.